Starcef 200mg capsules
Dexa Medica
Ingredients in every capsule
| Cefixime | 200 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | J – Antiinfectives for systemic use |
| ATC Level 2 | J01 – Antibacterials for Systemic Use |
| ATC Level 3 | J01D – Other Beta-Lactam Antibacterials in ATC |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
 |
Myanmar |
 |
Cambodia |
Dosage information
0 TO 18 YEARS, WEIGHT < 30 KG
For adults and children weighing ≥30 kg, the usual daily dose is 50-100 mg (potency) of STARCEF® given orally twice a day. Dosage should be adjusted according to age, body weight, and condition of the patients.
For severe infections, the dosage may be increased up to 200 mg (potency), given twice a day.
PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.
Indication
Treatment of infections caused by susceptible microorganisms, i.e.:
a. Urinary infections without complication caused by Escherichia coli and Proteus mirabilis.
b. Otitis media caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.
c. Pharyngitis and tonsillitis caused by Streptococcus pyogenes.
d. Acute bronchitis and acute exacerbation of chronic bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).